Search

everythinglearnresearchcommunity

for

Search:↓

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Estrogens are key for bone growth spurts in both boys and girls and affect growth into adulthood.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Skin aging can be slowed by targeting cells, hormones, and the microbiome.

Women's hair gets thinner and grayer as they age, with treatments available for hair loss and graying.

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.

More research is needed to determine if iron deficiency causes hair loss.

Hair ages due to various factors and treatments like minoxidil and finasteride can help, but more research and better public awareness are needed.

Anifrolumab effectively improved lupus headaches in a patient unresponsive to other treatments.

Hair loss from weight-loss treatments is usually temporary and reversible.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

Women with prediabetes may have a higher risk of PCOS-like changes, especially if they have impaired glucose tolerance.

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.

Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.

A patient regrew hair after a lung transplant using standard post-transplant medication.

Male pattern baldness may be caused by factors like poor blood circulation, scalp tension, stress, and hormonal imbalances, but the exact causes are still unclear.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Updated treatments for female hair loss include minoxidil, antiandrogens, hair transplants, and light therapy.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Skin changes can indicate hormonal imbalances and help diagnose endocrine disorders.